{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:42:39Z","timestamp":1791218559322,"version":"4.1.0"},"reference-count":100,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1673,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1582-4934.2010.01238.x","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T08:17:34Z","timestamp":1292314654000},"page":"187-195","source":"Crossref","is-referenced-by-count":91,"title":["Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL"],"prefix":"10.1111","volume":"15","author":[{"given":"Mingqing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,24]]},"reference":[{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB1|cit1","first-page":"141","article-title":"Intra-ocular growths (two cases, brother and sister, with peculiar vascular new growth, probably retinal, affecting both eyes)","volume":"14","author":"Collins","year":"1894","journal-title":"Trans Ophthalmol Soc UK."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","article-title":"Role of VHL gene mutation in human cancer","volume":"22","author":"Kim","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/332268a0","article-title":"Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma","volume":"332","author":"Seizinger","year":"1988","journal-title":"Nature."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.95.15.8817","article-title":"A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor","volume":"95","author":"Schoenfeld","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"11661","DOI":"10.1073\/pnas.95.20.11661","article-title":"pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation","volume":"95","author":"Iliopoulos","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/sj.onc.1202473","article-title":"Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity","volume":"18","author":"Blankenship","year":"1999","journal-title":"Oncogene."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nature Rev."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1128\/MCB.19.2.1486","article-title":"Transcription-dependent nuclear-cytoplas-mic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein","volume":"19","author":"Lee","year":"1999","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1073\/pnas.93.5.1770","article-title":"Nuclear\/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density","volume":"93","author":"Lee","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0955-0674(00)00194-0","article-title":"HIF-1 and mechanisms of hypoxia sensing","volume":"13","author":"Semenza","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1128\/MCB.22.9.2984-2992.2002","article-title":"Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300\/CBP","volume":"22","author":"Sang","year":"2002","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1101\/gad.12.2.149","article-title":"Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha","volume":"12","author":"Iyer","year":"1998","journal-title":"Genes Dev."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1101\/gad.12.21.3320","article-title":"The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development","volume":"12","author":"Tian","year":"1998","journal-title":"Genes Dev."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nm1102-1329b","article-title":"Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice","volume":"8","author":"Compernolle","year":"2002","journal-title":"Nat Med."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.0608382104","article-title":"Acute postnatal ablation of Hif-2alpha results in anemia","volume":"104","author":"Gruber","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1158\/0008-5472.CAN-04-4130","article-title":"Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells","volume":"65","author":"Wang","year":"2005","journal-title":"Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","article-title":"Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma","volume":"25","author":"Raval","year":"2005","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1038\/sj.emboj.7601300","article-title":"Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo","volume":"25","author":"Kim","year":"2006","journal-title":"EMBO J."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1091\/mbc.E06-05-0419","article-title":"The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha","volume":"18","author":"Hu","year":"2007","journal-title":"Mol Biol Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1074\/jbc.M208681200","article-title":"Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex","volume":"278","author":"Maynard","year":"2003","journal-title":"J Biol Chem."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1096\/fj.05-3788com","article-title":"Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma","volume":"19","author":"Maynard","year":"2005","journal-title":"FASEB J."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"32405","DOI":"10.1074\/jbc.C200328200","article-title":"Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus","volume":"277","author":"Makino","year":"2002","journal-title":"J Biol Chem."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/35107085","article-title":"Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression","volume":"414","author":"Makino","year":"2001","journal-title":"Nature."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB29|cit29","first-page":"4136","article-title":"Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein","volume":"61","author":"Yu","year":"2001","journal-title":"Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-5793(01)02159-7","article-title":"HIF-1-dependent transcriptional activity is required for oxygen- mediated HIF-1alpha degradation","volume":"491","author":"Berra","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1128\/MCB.02041-07","article-title":"Abnormal sympathoadrenal development and systemic hypotension in PHD3-\/-mice","volume":"28","author":"Bishop","year":"2008","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","article-title":"The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer","volume":"8","author":"Kaelin","year":"2008","journal-title":"Nature Rev."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.181341498","article-title":"HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation","volume":"98","author":"Yu","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1093\/emboj\/20.18.5197","article-title":"Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation","volume":"20","author":"Masson","year":"2001","journal-title":"EMBO J."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"26351","DOI":"10.1074\/jbc.C200273200","article-title":"Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family","volume":"277","author":"Hewitson","year":"2002","journal-title":"J Biol Chem."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.991402","article-title":"FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor","volume":"16","author":"Lando","year":"2002","journal-title":"Genes Dev."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1158\/0008-5472.CAN-05-4564","article-title":"The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha","volume":"66","author":"Dayan","year":"2006","journal-title":"Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/MCB.01514-06","article-title":"The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo","volume":"27","author":"Yan","year":"2007","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2008.10.016","article-title":"HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma","volume":"14","author":"Gordan","year":"2008","journal-title":"Cancer Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"Hif activation identifies early lesion in vhl kidneys: evidence for site-specific tumor suppressor funciton in the nephron","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","article-title":"Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes","volume":"463","author":"Dalgliesh","year":"2010","journal-title":"Nature."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/1541-7786.89.2.2","article-title":"Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-\/- tumors","volume":"2","author":"Zimmer","year":"2004","journal-title":"Mol Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","article-title":"Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth","volume":"1","author":"Kondo","year":"2003","journal-title":"PLoS Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","article-title":"Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein","volume":"1","author":"Kondo","year":"2002","journal-title":"Cancer Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1535-6108(02)00044-2","article-title":"The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma","volume":"1","author":"Maranchie","year":"2002","journal-title":"Cancer Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1073\/pnas.98.4.1583","article-title":"Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor","volume":"98","author":"Haase","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/MCB.25.8.3163-3172.2005","article-title":"Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice","volume":"25","author":"Rankin","year":"2005","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"22575","DOI":"10.1074\/jbc.M600288200","article-title":"Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environment","volume":"281","author":"Bracken","year":"2006","journal-title":"J Biol Chem."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2007.02.006","article-title":"HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity","volume":"11","author":"Gordan","year":"2007","journal-title":"Cancer Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1158\/0008-5472.CAN-09-0146","article-title":"Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney","volume":"69","author":"Beroukhim","year":"2009","journal-title":"Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nature Rev."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB54|cit54","first-page":"453","article-title":"Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways","volume":"1","author":"Jiang","year":"2003","journal-title":"Mol Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB55|cit55","first-page":"3803","article-title":"Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel- Lindau disease","volume":"62","author":"Zatyka","year":"2002","journal-title":"Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0090-4295(98)00132-0","article-title":"P53, bcl-2, and Bax expression in renal cell carcinoma","volume":"51","author":"Vasavada","year":"1998","journal-title":"Urology."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB58|cit58","first-page":"227","article-title":"p53 expression in human renal cell carcinoma: an immunohistochemical study and a literature outline of the cytogenetic characterization","volume":"86","author":"Tomasino","year":"1994","journal-title":"Pathologica."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molcel.2004.11.019","article-title":"Binding of natively unfolded HIF-1alpha ODD domain to p53","volume":"17","author":"Sanchez-Puig","year":"2005","journal-title":"Mol Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/32925","article-title":"Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha","volume":"392","author":"An","year":"1998","journal-title":"Nature."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature09141","article-title":"HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase","volume":"465","author":"Sendoel","year":"2010","journal-title":"Nature."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molcel.2006.04.006","article-title":"p53 stabilization and transactivation by a von Hippel-Lindau protein","volume":"22","author":"Roe","year":"2006","journal-title":"Mol Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1038\/sj.onc.1204525","article-title":"Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells","volume":"20","author":"Oya","year":"2001","journal-title":"Oncogene."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB64|cit64","first-page":"7076","article-title":"The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent anti-apoptotic pathway","volume":"63","author":"Qi","year":"2003","journal-title":"Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1128\/MCB.25.17.7546-7556.2005","article-title":"Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity","volume":"25","author":"An","year":"2005","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/0008-5472.CAN-09-2211","article-title":"NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel-Lindau inactivation in renal cell carcinomas","volume":"70","author":"Pantuck","year":"2010","journal-title":"Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2007.09.010","article-title":"pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2","volume":"28","author":"Yang","year":"2007","journal-title":"Mol Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.seminoncol.2006.06.001","article-title":"Molecular pathways in renal cell carcinoma-rationale for targeted treatment","volume":"33","author":"Kim","year":"2006","journal-title":"Semin Oncol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/hmg\/10.10.1029","article-title":"Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease","volume":"10","author":"Clifford","year":"2001","journal-title":"Hum Mol Genet."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","article-title":"von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF","volume":"10","author":"Hoffman","year":"2001","journal-title":"Hum Mol Genet."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ccr.2005.06.015","article-title":"Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer","volume":"8","author":"Lee","year":"2005","journal-title":"Cancer Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrm2233","article-title":"Cellular senescence: when bad things happen to good cells","volume":"8","author":"Campisi","year":"2007","journal-title":"Nat Rev Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ccr.2008.03.012","article-title":"VHL inactivation: a new road to senescence","volume":"13","author":"Kim","year":"2008","journal-title":"Cancer Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ncb1024","article-title":"Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts","volume":"5","author":"Parrinello","year":"2003","journal-title":"Nat Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1101\/gad.1471106","article-title":"HIF1alpha delays premature senescence through the activation of MIF","volume":"20","author":"Welford","year":"2006","journal-title":"Genes Dev."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1128\/MCB.02265-06","article-title":"Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia","volume":"27","author":"Bell","year":"2007","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ncb1699","article-title":"VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400","volume":"10","author":"Young","year":"2008","journal-title":"Nat Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1128\/MCB.01618-09","article-title":"Renal oxygenation suppresses VHL-loss-induced senescence that is caused by increased sensitivity to oxidative stress","volume":"30","author":"Welford","year":"2010","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ncb899","article-title":"Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL","volume":"5","author":"Hergovich","year":"2003","journal-title":"Nat Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1126\/science.1124534","article-title":"The primary cilium as the cell's antenna: signaling at a sensory organelle","volume":"313","author":"Singla","year":"2006","journal-title":"Science."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB82|cit82","first-page":"671","article-title":"Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction","volume":"38","author":"Zhuang","year":"1994","journal-title":"Acta Cytol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB83|cit83","first-page":"2089","article-title":"Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients","volume":"149","author":"Lubensky","year":"1996","journal-title":"Am J Pathol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ackd.2006.01.021","article-title":"Renal cystic disease: the role of the primary cilium\/centrosome complex in pathogenesis","volume":"13","author":"Siroky","year":"2006","journal-title":"Adv Chronic Kidney Dis."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1128\/MCB.00232-06","article-title":"Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3","volume":"26","author":"Hergovich","year":"2006","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1158\/0008-5472.CAN-06-0501","article-title":"Primary cilium formation requires von hippel-lindau gene function in renal-derived cells","volume":"66","author":"Lutz","year":"2006","journal-title":"Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1158\/0008-5472.CAN-05-2670","article-title":"Regulation of E-cadherin expression by VHL and hypoxia-inducible factor","volume":"66","author":"Esteban","year":"2006","journal-title":"Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/emboj.2008.96","article-title":"pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation","volume":"27","author":"Frew","year":"2008","journal-title":"EMBO J."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.2215\/CJN.02020309","article-title":"Renal cystic diseases and renal neoplasms: a mini-review","volume":"4","author":"Bonsib","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/35067088","article-title":"Multifunctional strands in tight junctions","volume":"2","author":"Tsukita","year":"2001","journal-title":"Nat Rev Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.onc.1210709","article-title":"Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2","volume":"27","author":"Kurban","year":"2008","journal-title":"Oncogene."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1128\/MCB.26.7.2519-2530.2006","article-title":"pVHL function is essential for endothelial extra-cellular matrix deposition","volume":"26","author":"Tang","year":"2006","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","article-title":"The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix","volume":"1","author":"Ohh","year":"1998","journal-title":"Mol Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1371\/journal.pbio.0020289","article-title":"Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans","volume":"2","author":"Bishop","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/embor.2008.19","article-title":"NEDD8 acts as a \u2018molecular switch\u2019 defining the functional selectivity of VHL","volume":"9","author":"Russell","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/MCB.24.8.3251-3261.2004","article-title":"pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development","volume":"24","author":"Stickle","year":"2004","journal-title":"Mol Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-05-3236","article-title":"von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms","volume":"66","author":"Calzada","year":"2006","journal-title":"Cancer Res."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrc1691","article-title":"The concept of synthetic lethality in the context of anticancer therapy","volume":"5","author":"Kaelin","year":"2005","journal-title":"Nature Rev."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ccr.2008.06.004","article-title":"A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy","volume":"14","author":"Turcotte","year":"2008","journal-title":"Cancer Cell."},{"key":"10.1111\/j.1582-4934.2010.01238.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"16484","DOI":"10.1073\/pnas.0806574105","article-title":"Kinase requirements in human cells: III. Altered kinase requirements in VHL-\/-cancer cells detected in a pilot synthetic lethal screen","volume":"105","author":"Bommi-Reddy","year":"2008","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1582-4934.2010.01238.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1582-4934.2010.01238.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T09:40:32Z","timestamp":1685871632000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1582-4934.2010.01238.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01238.x","relation":{},"ISSN":["1582-1838"],"issn-type":[{"value":"1582-1838","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}